Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.
Saved in:
| Title: | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma. |
|---|---|
| Authors: | Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. surbhi.sidana@stanford.edu., Hosoya H; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Jensen A; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA, USA., Liu L; City of Hope Cancer Center, Duarte, CA, USA., Goyal A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Hovanky V; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Correlative Science Unit, Stanford University, Stanford, CA, USA., Bharadwaj S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Latchford T; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Leahy S; City of Hope Cancer Center, Duarte, CA, USA., Mei M; City of Hope Cancer Center, Duarte, CA, USA., Budde LE; City of Hope Cancer Center, Duarte, CA, USA., Muffly LS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Htut M; City of Hope Cancer Center, Duarte, CA, USA., Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Janakiram M; City of Hope Cancer Center, Duarte, CA, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 Oct 13; Vol. 13 (1), pp. 158. Date of Electronic Publication: 2023 Oct 13. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
